Pyoderma gangrenosum treated with clofazimine. Report of three cases (Q70730875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Pyoderma gangrenosum treated with clofazimine. Report of three cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

E C Kark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

B R Davis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

J R Pomeranz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

English

0 references

publication date

1 February 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

152-159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

Clofazimine. A new agent for the treatment of pyoderma gangrenosum

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970018-5

7 January 2021

Clofazimine Therapy of Lepromatous Leprosy Caused by Dapsone-Resistant Mycobacterium Leprae *

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970018-5

7 January 2021

Immunologically-mediated acute renal failure of nonglomerular origin in the course of systemic lupus erythematosus [SLE]. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970018-5

7 January 2021

Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970018-5

7 January 2021

10.1016/S0190-9622(81)70018-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7217385%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference